Document:

Exhibit 10.64

 

GUESS ?, INC.

1996 NON-EMPLOYEE DIRECTORS’

STOCK GRANT AND STOCK OPTION PLAN

 

(As Amended and Restated Effective June 20,
2005)

 

1.             Purpose of
the Plan.

 

The purpose of this Plan is to enable the
Company to attract and retain as non-employee directors individuals with
superior training, experience and ability and to provide additional incentive
to such Eligible Directors by giving them an opportunity to participate in the
ownership of the Company.

 

2.             Definitions.

 

For purposes of the Plan, the following terms
shall be defined as set forth below:

 

“Affiliate” and “Associate”
have the respective meanings ascribed to such terms in Rule 12b-2
promulgated under the Exchange Act.

 

“Award” means any award of an Option
or Restricted Stock, or any combination thereof, authorized by and granted
under this Plan.

 

“Award Agreement” means a written
document issued by the Company to a Participant setting forth the terms and
conditions of an Award that has been granted under the Plan.

 

“Beneficial Owner” has the meaning
ascribed to such term in Rule 13d-3 promulgated under the Exchange
Act.

 

“Board” means the Board of Directors
of the Company.

 

“Code” means the Internal Revenue Code
of 1986, as amended from time to time, and any successor thereto.

 

“Combined Voting Power” means the
combined voting power of the Company’s then outstanding voting securities.

 

“Common Stock” means the Common Stock
of the Company, par value $.01 per share.

 

“Company” means Guess ?, Inc., a
Delaware corporation, including any wholly owned Subsidiary or affiliate, or
any successor organization.

 

“Disability” means permanent and total
disability within the meaning of Section 22(e)(3) of the Code.

 

1

 

“Election Date” means January 15
of the relevant Election Period, provided, however, that the Election Date for
an Eligible Director’s initial Election Period shall be the day of initial
election or appointment to the Board.

 

“Election Period” means the calendar
year, provided, however, that if an Eligible Director is initially elected or
appointed to the Board as of a date other than January 1, the initial
Election Period for such Eligible Director shall be the remainder of the year
of initial election or appointment.

 

“Eligible Director” means a person who
is a member of the Board and who is not an employee of the Company.

 

“Eligibility Date” means the first
business day of each of the Company’s fiscal years, commencing January 1,
1997, while this Plan is in effect.

 

“Exchange Act” means the Securities
Exchange Act of 1934, as amended.

 

“Fair Market Value” means, on any
given date, the closing price of the shares of Common Stock, as reported on the
New York Stock Exchange for such date or, if Common Stock was not traded on
such date, on the next preceding day on which Common Stock was traded; provided
that if the Common Stock is not then traded on the New York Stock Exchange,
Fair Market Value means the fair market value thereof as of the relevant date
of determination as determined in accordance with a valuation methodology
approved by the Board.

 

“Option” means any option to purchase
shares of the Common Stock of the Company granted pursuant to this Plan.

 

“Parent” means any corporation which
is a “parent corporation” within the meaning of Section 424(e) of the
Code with respect to the Surviving Entity.

 

“Participant” means an Eligible
Director who has been granted an Award under this Plan.

 

“Person” means any person or “group”
within the meaning of Section 13(d)(3) or Section 14(d)(2) of
the Exchange Act.

 

“Plan” means the Guess ?, Inc.
1996 Non-Employee Directors’ Stock Grant and Stock Option Plan, as hereinafter
amended from time to time.

 

“Rules” means the regulations
promulgated by the Securities and Exchange Commission under Section 16 of
the Exchange Act, as amended from time to time.

 

“Subsidiary” means (i) any
corporation which is a “subsidiary corporation” within the meaning of Section 424(f) of
the Code with respect to the Company or (ii) any other corporation or
other entity in which the Company, directly or indirectly, has an equity or
similar interest and which the Board designates as a subsidiary for purposes of
the Plan.

 

“Surviving Entity” has the meaning
ascribed to it in Section 10(b) hereof.

 

2

 

Except where otherwise indicated by the
context, any masculine terminology used herein shall also include the feminine
and vice versa, and the definition of any term herein in the singular shall
also include the plural and vice versa.

 

3.             Shares
Subject to the Plan.

 

Except as provided in Section 9, the
aggregate number of shares of Common Stock that may be issued under the Plan is
500,000.  Such shares may include
authorized but unissued shares of Common Stock, treasury shares or a combination
of both. In the event the number of shares of Common Stock issued under the
Plan and the number of shares of Common Stock subject to outstanding Awards
equals the maximum number of shares of Common Stock authorized under the Plan,
no further awards shall be made unless the Plan is amended (in accordance with
the Rules, if necessary) or additional shares of Common Stock become available
for further awards under the Plan. 
Shares of Common Stock that are subject to Options granted under the
Plan that terminate, expire or are canceled without having been exercised, and
any restricted shares of Common Stock subject to a Restricted Stock Award that
are forfeited, cancelled, or for any other reason do not vest shall again be
available for subsequent Awards under the Plan.

 

4.             Administration
of the Plan.

 

(a)     Administration.  The Plan shall be administered by the Board.
Subject to the provisions of the Plan, and notwithstanding the intent that the
Award grants under the Plan be self-effectuating to the maximum extent
possible, the Board shall be authorized to:

 

(i)            adopt,
revise and repeal such administrative rules, guidelines and practices governing
this Plan as it shall from time to time deem advisable;

 

(ii)           interpret
the terms and provisions of the Plan and any Award issued under the Plan (and
any agreements relating thereto), and otherwise settle all claims and disputes
arising under the Plan;

 

(iii)          delegate
responsibility and authority for the operation and administration of the Plan,
appoint employees and officers of the Company to act on its behalf, and employ
persons to assist in the fulfilling of its responsibilities under the Plan; and

 

(iv)          otherwise
supervise the administration of the Plan; provided, however, that the Board
shall have no discretion with respect to the selection of Eligible Directors to
receive Awards hereunder, the number of shares of Common Stock covered by such
Award or the price or timing of any Awards granted hereunder; provided further
that any action by the Board relating to the Plan will be taken only if
approved by the affirmative vote of a majority of the directors who are not
then eligible to participate under the Plan.

 

(b)     Delegation
to a Committee.  The Board may
delegate to a committee of the Board any or all of its authority for
administration of the Plan and, if such delegation occurs, all references to
the Board in this Plan shall be deemed references to the committee to the
extent provided in the resolution establishing the committee.

 

3

 

(c)     Loans
to Participants.  The Board, in its
absolute discretion, may provide that the Company loan to Participants
sufficient funds to exercise any Option. 
The Board shall have the authority to make such determinations at any
time and shall establish repayment terms, including installments, maturity and
interest rates.

 

5.             Option
Grants.

 

(a)     Number
of Options Granted.  The following
Options shall be automatically granted to each Eligible Director under the
Plan, without further approval or authorization of the Board or any other
person:

 

(i)            One-Time
Grant.  Each Eligible Director
remaining in office on May 13, 2002 shall be awarded an Option to purchase
4,500 shares of Common Stock as of May 13, 2002.

 

(ii)           New
Director Grants.  Each person who
first becomes an Eligible Director on or after May 13, 2002 shall be
awarded an Option to purchase 12,000 shares of Common Stock as of the date such
person first becomes an Eligible Director.

 

(iii)          Annual
Grants.  On each Eligibility Date,
each Eligible Director who has not been an employee of the Company at any time
during the immediately preceding 12 months shall be awarded an Option to
purchase 7,500 shares of Common Stock, provided, however, that an Eligible
Director whose initial election or appointment to the Board occurs after September 30
of a given year (or, if the fiscal year of the Company shall be other than the
calendar year, whose initial election or appointment to the Board occurs more
than nine months after the start of the Company’s fiscal year) shall not
receive an award pursuant to this clause (iii) on the first Eligibility
Date to occur after such initial election or appointment.

 

In addition to
the Options granted under this Section 5, Eligible Directors may also be
awarded Options pursuant to the election provided for in Section 6 below.

 

(b)     Option
Price.  The Option price per share of
Common Stock covered by an Option granted under this Section 5 shall be
equal to the Fair Market Value of one share of Common Stock on the date of
grant.

 

(c)     Exercisability.  Subject to the other terms and conditions of
the Plan, Options granted under this Section 5 shall vest and become
exercisable with respect to one-fourth of the shares of Common Stock covered
thereby on each anniversary of the date of grant, provided that the Eligible
Director shall have continued in service on the Board until such date.  In no case may an Option be exercised as to
less than 100 shares at any one time (or the remaining shares covered by the
Option if less than 100) during the term of the Option.  Only whole shares shall be issued pursuant to
the exercise of any Option.

 

6.             Elections to
Receive Options in Lieu of Annual Retainer Fees.

 

(a)     General;
Time and Manner of Making Election. 
An Eligible Director may elect to receive, in lieu of his or her annual
cash retainer fees for service on the Board, Options

 

4

 

having the
terms and conditions set forth in this Section 6 and in Section 7
below.  Such an election shall be made
with respect to any Election Period by completing, signing and returning to the
Company, on or prior to the Election Date, a election form provided for such
purpose or other documentation reasonably acceptable to the general counsel of
the Company.  Elections pursuant to this Section 6(a) may
be made only with respect to the entire amount of an Eligible Director’s annual
cash retainer fees for service on the Board during an Election Period.  Elections shall not be available either with
respect to any portion of such annual retainer fee or with respect to any
attendance fees or fees for service on, or as chairman of, a committee.  An election, once made, shall be irrevocable.

 

(b)     Number
of Shares Subject to Option.  The
number of shares of Common Stock subject to an Option awarded pursuant to an
election made as provided in Section 6(a) above shall be calculated
using the formula (A x B)/C, where “A” equals the dollar amount of annual
retainer fee deferred, “B” equals 2.50 and “C” equals the Fair Market Value of
one share of Common Stock on the applicable Election Date.  If the foregoing yields a fractional share,
the number of shares subject to the Option shall be rounded up to the nearest
whole share.

 

(c)     Date
of Grant; Option Price.  Options
awarded pursuant to this Section 6 will be granted as of the relevant
Election Date.  The Option price per
share of Common Stock covered by an Option granted under this Section 6
shall be equal to the Fair Market Value of one share of Common Stock on the
date of grant.

 

(d)     Exercisability.  Subject to the other terms and conditions of
the Plan, Options granted under this Section 6 shall vest and become
exercisable with respect to one-fourth of the shares of Common Stock covered
thereby on the first day of each of the four fiscal quarters following the date
of grant, provided that the Eligible Director shall have continued in service
on the Board until such date.  In no case
may an Option be exercised as to less than 100 shares at any one time (or the
remaining shares covered by the Option if less than 100) during the term of the
Option.  Only whole shares shall be
issued pursuant to the exercise of any Option.

 

7.             General
Terms and Conditions of Options.

 

All Options granted under the Plan shall have
the following terms and conditions:

 

(a)     Award
Agreement.  Each Option shall be
evidenced by an Award Agreement containing such terms and conditions which are
not inconsistent with the terms of the Plan. 
Award Agreements relating to Options may, in the discretion of the
Board, provide restrictions on transfer of shares of Common Stock acquired upon
exercise of any Option during a specified period.

 

(b)     Non-qualified
Stock Options.  All Options granted
hereunder shall be non-qualified stock options and shall not be “incentive
stock options” within the meaning of Section 422 of the Code.

 

(c)     Option
Term. The term of each Option shall be ten years.  No Option shall be exercised by any person
after expiration of the term of the Option.

 

5

 

(d)     Method
of Exercise.

 

(i)            Exercise
of Options shall be subject to any trading policy of the Company applicable to
members of the Board, including without limitation any “blackout” period
requirements or other restrictions on the time during which Options may be
exercised.

 

(ii)           Shares
may be purchased or acquired pursuant to an Option granted hereunder by giving
written notice of exercise to the Company, specifying the number of shares as
to which the Participant desires to exercise the Option, and containing any
representations required by the Board. 
On or before the date specified for completion of the purchase of shares
pursuant to an Option, the Participant must have paid the Company the full purchase
price of such shares in cash, certified or bank check, or other instrument
acceptable to the Board.  As determined
by the Board in its sole discretion, payment in full or in part may also be
made by tendering to the Company shares of previously acquired unrestricted
Common Stock of the Company (having a Fair Market Value as of the date the
Option is exercised equal to the exercise price (or such portion thereof)),
provided that any shares that were acquired from the Company upon exercise of a
stock option or otherwise must have been owned by the Participant for at least
six months as of the date of delivery. 
In its discretion, in accordance with rules and procedures
established by the Board for this purpose, the Board may also permit an
Participant to exercise an Option through a “cashless exercise” procedure
approved by the Board involving a broker or dealer approved by the Board,
provided that the Participant has delivered an irrevocable notice of exercise
(the “Notice”) to the broker or dealer and such broker or dealer
agrees:  (A) to sell immediately the
number of shares of Common Stock specified in the Notice to be acquired upon
exercise of the Option in the ordinary course of its business, (B) to pay
promptly to the Company the aggregate exercise price (plus the amount necessary
to satisfy any applicable tax liability) and (C) to pay to the Participant
the balance of the proceeds of the sale of such shares over the amount
determined under clause (B) of this sentence, less applicable commissions
and fees; provided, however, that the Board may modify the provisions of this
sentence to the extent necessary to conform the exercise of the Option to
Regulation T under the Exchange Act or any other applicable rules.  The manner in which the exercise price may be
paid may be subject to certain conditions specified by the Board, including,
without limitation, conditions intended to avoid the imposition of liability
against the individual under Section 16 of the Exchange Act.

 

(iii)          If
requested by the Board, the Participant shall deliver the Award Agreement
evidencing an exercised Option to the Secretary of the Company, who shall
endorse thereon a notation of such exercise and return such Award Agreement to
the Participant exercising the Option. 
No fractional shares (or cash in lieu thereof) shall be issued upon
exercise of an Option and the number of shares that may be purchased upon
exercise shall be rounded to the nearest number of whole shares.

 

6

 

(e)     Non-transferability.  No Option granted under the Plan or any
rights or interests therein may be sold, transferred, assigned, pledged or
otherwise encumbered or disposed of, except by will, or the laws of descent and
distribution or pursuant to a “qualified domestic relations order” (“QDRO”)
as defined in the Code or Title I of the Employee Retirement Income Security
Act of 1974, as amended, and the rules and regulations thereunder; provided, however,
that the Board may, subject to such terms and conditions as the Board shall
specify, permit the transfer of an Option granted after August 15, 1996 to
an Participant’s family members or to one or more trusts established in whole
or in part for the benefit of one or more of such family members.  During the Participant’s lifetime, all
Options shall be exercisable only by the Participant or, if applicable, the “alternate
payee” under a QDRO, or the family member or trust to whom such Option has been
transferred in accordance with the previous sentence.

 

(f)      Termination
by Reason of Death.  In the event of
the death of an Participant, any Option held by such Participant may thereafter
be exercised, to the extent exercisable on the date of death, by the legal
representative of the estate or legatee of the Participant under the will of
the Participant for a period of one year from the date of such death or until
the expiration of the stated term of such Option, whichever period is shorter,
and to the extent not exercisable on the date of death, such Option shall be
forfeited.

 

(g)     Termination
by Reason of Disability.  In the
event of the Disability of an Participant, any Option held by such Participant
may thereafter be exercised by the Participant, to the extent it was
exercisable at the time of such Disability, for a period of one year from the
date of such Disability or until the expiration of the stated term of such
Option, whichever period is shorter, and to the extent not exercisable on the
date of Disability, such Option shall be forfeited; provided, however,
that if the Participant dies within such one-year period, any unexercised
Option held by such Participant shall thereafter be exercisable to the extent
it was exercisable at the time of death for a period of one year from the date
of such death or until the expiration of the stated term of such Option, whichever
period is shorter.

 

(h)     Other
Terminations.  If an Participant
ceases to be an Eligible Director for any reason other than death or
Disability, any Option held by such Participant may thereafter be exercised by
the Participant, to the extent it was exercisable at the time of such
termination, for a period of six months from the date of such termination or
the expiration of the stated term of such Option, whichever period is shorter,
and to the extent not exercisable on the date of termination, such Option shall
be forfeited; provided, however, that if the Participant dies
within such six-month period, any unexercised Option held by such Participant
shall thereafter be exercisable, to the extent to which it was exercisable at
the time of death, for a period of one year from the date of such death or
until the expiration of the stated term of the Option, whichever period is
shorter.

 

8.             Restricted
Stock Grants

 

(a)     Grants

 

(i)            One-Time Grants.  Each Eligible Director remaining in office on
May 13, 2002 shall be granted a Restricted Stock Award for 500 restricted
shares of Common Stock as of May 13, 2002. 
Each Eligible Director remaining in office on July 1, 2005

 

7

 

shall be granted a Restricted Stock Award for 1,000 restricted shares
of Common Stock as of July 1, 2005.

 

(ii)           Initial Grant.  Each person who first becomes an Eligible
Director on or after May 13, 2002 shall be granted a Restricted Stock
Award for 2,000 restricted shares of Common Stock on the date such person first
becomes an Eligible Director.

 

(iii)          Annual
Awards. 
On each Eligibility Date occurring on or after July 1,
2005, each Eligible Director who has not been an employee of the Company at any
time during the immediately preceding 12 months shall be granted a Restricted
Stock Award for 4,000 restricted shares of Common Stock; provided, however,
that an Eligible Director whose initial election or appointment to the Board
occurs after September 30 of a given year (or, if the fiscal year of the
Company shall be other than the calendar year, whose initial election or
appointment to the Board occurs more than nine months after the start of the
Company’s fiscal year) shall not receive an award pursuant to this clause (iii) on
the first Eligibility Date to occur after such initial election or appointment.

 

(b)     Restricted Stock Awards.  Stock certificates or book entries evidencing
shares of restricted stock subject to a Restricted Stock Award pending the
lapse of the restrictions shall bear a legend or notation making appropriate
reference to the restrictions imposed hereunder and, if so provided by the
Board, (if in certificate form) shall be held by the Corporation or by a third
party designated by the Board until the restrictions on such shares shall have
lapsed and the shares shall have vested in accordance with the provisions of
the Award and the provisions hereof. 
Restricted Stock Awards will be evidenced by an Award Agreement
containing such terms and conditions which are not inconsistent with the terms
of the Plan.

 

(c)     Vesting.  Each Restricted Stock Award granted under
this Section 8 shall become vested as to 100% of the total number of
shares of Common Stock subject thereto upon the earlier of (i) the second
anniversary of the date of grant or (ii) the completion of the Eligible
Director’s full term.  Promptly after the
vesting date and satisfaction of all applicable restrictions, a certificate or
certificates evidencing the number of the shares of Common Stock as to which
the restrictions have lapsed shall be delivered to the Participant holding the
Award (to the extent that the certificate(s) had not previously been
delivered).  Certificates evidencing
vested shares and any other amounts deliverable in respect thereof shall be
delivered and paid only to the Participant or his or her personal
representative, as the case may be.

 

(d)     Transfer Restrictions.  Prior to the time that they have become
vested, neither the restricted shares comprising any Restricted Stock Award,
nor any interest therein, amount payable in respect thereof, or Restricted
Property (as defined in 8(e)), may be sold, assigned, transferred, pledged or
otherwise disposed of, alienated or encumbered, either voluntarily or
involuntarily.  The transfer restrictions
in the preceding sentence shall not apply to (i) transfers to the Company,
(ii) the designation of a beneficiary to receive benefits in the event of
the Eligible Director’s death, or of the Eligible Director has died, transfers
to the Eligible Director’s beneficiary, or, in the absence of a validly
designated beneficiary, transfers by will or the laws of descent and
distribution.

 

8

 

(e)     Voting; Dividends.  After the applicable date of grant of a
Restricted Stock Award, the Participant holding the Restricted Stock Award
shall have voting rights and dividend rights with respect to the shares of
Common Stock subject to the award.  Any
securities or other property receivable in respect of the shares subject to the
award as a result of any dividend or other distribution (other than cash
dividends), conversion or exchange of or with respect to the shares (“Restricted
Property”) will be subject to the restrictions set forth in this Plan to the
same extent as the shares to which such securities or other property relate and
shall be held and accumulated for the benefit of the Participant, but subject
to such risks.  The Participant’s voting
and dividend rights shall terminate immediately as to any shares that are
forfeited back to the Company in accordance with Section 8(f).

 

(f)      Effect of a Termination of Service.  If a Participant ceases to be
a member of the Board for any reason any shares subject to the Participant’s
Restricted Stock Award that are not fully vested and free from restriction as
of the Participant’s termination of service shall thereupon be forfeited and
returned to the Company.

 

9.             Amendment
and Termination.

 

The Board may amend, alter, suspend or
terminate the Plan in whole or in part at any time and from time to time;
provided, however, that any amendment, alteration, suspension or termination
which, under the requirements of applicable federal or state law or regulation
or the rules of any stock exchange or automated quotation system on which
the Common Stock may then be listed or quoted must be approved by the
stockholders of the Company, shall not be effective unless and until such
stockholder approval has been obtained in compliance with such law.  The Board may amend the terms of any Award
theretofore granted, prospectively or retroactively, but no such amendment
shall impair the rights of any Participant without the Participant’s consent.
Notwithstanding any provision herein to the contrary, the Board shall have
broad authority to amend the Plan or any Award to take into account changes in
applicable tax laws, securities laws, accounting rules and other
applicable state and federal laws.

 

10.          Changes in
Capital Structure.

 

(a)     In
the event of any change in the outstanding Common Stock by reason of a stock
dividend, recapitalization, reorganization, merger, consolidation, stock split,
combination or exchange of shares, (i) such proportionate adjustments as
may be necessary (in the form determined by the Board in its sole discretion)
to reflect such change shall be made to prevent dilution or enlargement of the
rights of Participants under the Plan with respect to the aggregate number of
shares of Common Stock for which awards in respect thereof may be granted under
the Plan, the number of shares of Common Stock covered by each outstanding
Option, and the exercise price in respect thereof and (ii) the Board may
make such other adjustments, consistent with the foregoing, as it deems
appropriate in its sole discretion.

 

(b)     In
the event of a change in control of the Company, (i) all outstanding
Options granted hereunder shall become fully exercisable as of the date of the
Change in Control, whether or not then exercisable and shares subject to
Restricted Stock Awards then outstanding under the Plan shall vest 100% free of
restrictions as of the date of the Change in Control, and  (ii) in the case of a change in control
involving a merger of, and consolidation involving, the

 

9

 

Company in
which the Company is (A) not the surviving corporation (the “Surviving
Entity”) or (B) becomes a wholly owned subsidiary of the Surviving
Entity or any Parent thereof, each outstanding Option granted hereunder and not
exercised (a “Predecessor Option”) shall be converted into an option (a “Substitute
Option”) to acquire common stock of the Surviving Entity or its Parent,
which Substitute Option shall have substantially the same terms and conditions
as the Predecessor Option, with appropriate adjustments as to the number and
kind of shares and exercise prices.  A “change
in control” shall be deemed to have occurred when (A) any Person (other
than (x) the Company, any Subsidiary of the Company, any employee benefit plan
of the Company or of any Subsidiary of the Company, or any person or entity
organized, appointed or established by the Company or any Subsidiary of the
Company for or pursuant to the terms of any such plan or (y) Maurice Marciano,
Paul Marciano or Armand Marciano, or any trust established in whole or in part
for the benefit of one or more of them or their family members, or any other
entity controlled by one or more of them), alone or together with its
Affiliates and Associates (collectively, an “Acquiring Person”), shall
become the Beneficial Owner of twenty percent (20%) or more of the then
outstanding shares of Common Stock or the Combined Voting Power of the Company
(except pursuant to an offer for all outstanding shares of Common Stock at a
price and upon such terms and conditions as a majority of the Continuing
Directors determine to be in the best interests of the Company and its
shareholders (other than an Acquiring Person on whose behalf the offer is being
made)), (B) during any period of two consecutive years, individuals who at
the beginning of such period constitute the Board, and any new director (other
than a director who is a representative or nominee of an Acquiring Person)
whose election by the Board or nomination for election by the Company’s
shareholders was approved by a vote of at least a majority of the directors
then still in office who either were directors at the beginning of the period
or whose election or nomination for election was previously so approved
(collectively, the “Continuing Directors”), cease for any reason to
constitute a majority of the Board, (C) the shareholders of the Company
approve a merger or consolidation of the Company with any other corporation,
other than a merger or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted into voting
securities of the Surviving Entity or any Parent of such Surviving Entity) at
least 80% of the Combined Voting Power of the Company, such Surviving Entity or
the Parent of such Surviving Entity outstanding immediately after such merger
or consolidation, or (D) the shareholders of the Company approve a plan of
reorganization (other than a reorganization under the United States Bankruptcy
Code) or complete liquidation of the Company or an agreement for the sale or
disposition by the Company of all or substantially all of the Company’s assets;
provided, however, that a change in control shall
not be deemed to have occurred in the event of (x) a sale or conveyance in
which the Company continues as a holding company of an entity or entities that
conduct all or substantially all of the business or businesses formerly
conducted by the Company or (y) any transaction undertaken for the purpose of
incorporating the Company under the laws of another jurisdiction, if such
transaction does not materially affect the beneficial ownership of the Company’s
capital stock.

 

11.          Unfunded Status of the Plan.

 

The Plan is unfunded.  Nothing contained herein shall give any such
Participant any rights that are greater than those of a general creditor of the
Company. In its sole discretion, the Board may authorize the creation of trusts
or other arrangements to meet the obligations

 

10

 

created under the Plan to deliver Common
Stock or payments in lieu thereof with respect to awards hereunder.

 

12.          Effective Date and Term of the Plan.

 

The Plan became effective on July 30,
1996 and was last amended and restated as set forth herein as of June 20,
2005.  The Plan shall continue in effect
until the earlier of (a) ten years from the date of the first grant of
Awards or (b) the termination of the Plan by action of the Board.  No Awards shall be granted pursuant to the
Plan on or after such termination date, but Awards granted prior to such date
may extend beyond that date.  The Board
shall have the right to suspend or terminate the Plan at any time except with
respect to any Awards then outstanding.

 

13.          General
Provisions.

 

(a)     Representations
by Participants.  The Board may
require each Participant to represent to and agree with the Company in writing
that the Participant is acquiring the shares of Common Stock without a view to
distribution or other disposition thereof. 
The certificates for such shares may include any legend that the Company
deems appropriate to reflect any restrictions on transfer.

 

(b)     Continuance
of Service Required.  The vesting schedule applicable
to an Award requires continued service through each applicable vesting date as
a condition to the vesting of the applicable installment of the Award and the
rights and benefits under this Plan. 
Service for only a portion of a vesting period, even if substantial,
will not entitle the award recipient to any proportionate vesting or avoid or
mitigate a termination of rights and benefits upon or following a termination
of services as provided in Sections 7(f), 7(g), 7(h) or 8(f), as
applicable.  Nothing contained in this
Plan constitutes a service commitment by the Company, confers upon any Award
recipient any right to remain in service to the Company, interferes in any way
with the right of the Company at any time to terminate such service, or affects
the right of the Company or any affiliate to increase or decrease the recipient’s
other compensation.

 

(c)     No
Restrictions on Adoption of Other Compensation Arrangements. Nothing
contained in this Plan shall prevent the Board from adopting other or
additional compensation arrangements (subject to stockholder approval, if such
approval is required) and such arrangements may be either generally applicable
or applicable only in specific cases.

 

(d)     No
Right to Re-Election.  The adoption
of the Plan shall not interfere in any way with the right of the Company to
terminate its relationship with any of its directors at any time.

 

(e)     No
Stockholder Rights.  Except as
otherwise expressly authorized by the Board or this Plan: (a) a
Participant shall not be entitled to any privilege of stock ownership as to any
shares of Common Stock not actually delivered to and held of record by the
Participant, and (b) no adjustment will be made for dividends or other
rights as a stockholder for which a record date is prior to such date of
delivery.

 

(f)      Tax
Withholding.  No later than the date
as of which an amount first becomes includable in the gross income of the
Participant for applicable income tax purposes with respect

 

11

 

to any award
under the Plan, the Participant shall pay to the Company or make arrangements
satisfactory to the Board regarding the payment of any federal, state or local
taxes of any kind required by law to be withheld with respect to such
amount.  Unless otherwise determined by
the Board, in accordance with rules and procedures established by the
Board, the minimum required withholding obligations may be settled with Common
Stock, including Common Stock that is part of the award that gives rise to the
withholding requirement.  The obligation
of the Company under the Plan shall be conditional upon such payment or
arrangements and the Company shall, to the extent permitted by law, have the
right to deduct any such taxes from any payment of any kind otherwise due to
the Participant.

 

(g)     Issue
and Transfer Taxes.  The Board may
agree to require the Company to pay issuance or transfer taxes on shares issued
pursuant to the exercise of an Option under the Plan.

 

(h)     Applicable
Law.  The Plan shall be governed by
and subject to the laws of the State of Delaware and to all applicable laws and
to the approvals by any governmental or regulatory agency as may be required.

 

(i)      Severability.  If any provision of this Plan shall be held
illegal or invalid for any reason, such illegality or invalidity shall not
affect the remaining provisions of this Plan, but this Plan shall be construed
and enforced as if such illegal or invalid provision had never been included
herein.

 

(j)      Compliance
with Rule 16b-3.  The Plan
is intended to comply with Rule 16b-3 under the Exchange Act or its
successors under the Exchange Act and the Board shall interpret and administer
the provisions of the Plan or any Award Agreement in a manner consistent
therewith.  To the extent any provision
of the Plan or Award Agreement or any action by the Board fails to so comply,
it shall be deemed null and void, to the extent permitted by law and deemed
advisable by the Board.  Moreover, in the
event the Plan or an Award Agreement does not include a provision required by Rule 16(b)(3) to
be stated therein, such provision (other than one relating to eligibility requirements,
or the price and amount of Awards) shall be deemed automatically to be
incorporated by reference into the Plan or such Award Agreement.

 

(k)     Expenses.  All expenses and costs in connection with the
administration of the Plan or the issuance of Options hereunder shall be borne
by the Company.

 

(l)            Headings.  The headings of sections herein are included
for convenience of reference and shall not affect the meaning of any of the
provisions of the Plan.

 

12BP - x1-54415 - Cord Blood America, Inc. - Exhibit 10.25

EXHIBIT 10.25

AMENDED AND RESTATED

PROMISSORY NOTE

June 21, 2005

	Jersey City, New Jersey

	$600,000.00

FOR VALUE RECEIVED, the undersigned, CORD BLOOD AMERICA, INC., a Florida corporation (the “Company”), promises to pay CORNELL CAPITAL PARTNERS, LP (the “Lender”) at 101 Hudson Street, Suite 3700, Jersey City, New Jersey 07302 or other address as the Lender shall specify in writing, the principal sum of up to Six Hundred Thousand Dollars ($600,000) and interest on the unpaid principal sum advanced to the Company by the Lender at the annual rate of twelve percent (12%) on the unpaid balance pursuant to the following terms: 

WHEREAS, The parties intend that this Amended and Restated Promissory Note (the “Note”) amend and replace the Promissory Note dated April 27, 2005 issued to the Lender by the Company.

WHEREAS, pursuant to a Registration Rights Agreement dated March 22, 2005 between the Company and the Lender (the “Registration Rights Agreement”), the Company has filed a registration statement with the U.S. Securities and Exchange Commission (“SEC”) to register for resale shares of the Company’s common Stock, par value $0.0001 (“Common Stock”) to be issued to the Lender in connection with the Standby Equity Distribution Agreement dated March 22, 2005 between the Company and the Lender (the “SEDA”); and

WHEREAS, on April 27, 2005 the Company and the Lender entered into a Pledge and Escrow Agreement among the Lender, the Company, Matthew L. Schissler and Stephanie A. Schissler, and David Gonzalez, Esq. (the “Pledge Agreement”) (collectively, this Note and the Pledge Agreement are referred to as the “Transaction Documents”).

1.

Funding By Lender. Subject to the notification and satisfaction of the conditions to the Closings set forth herein, the principal amount of One Hundred Seventy Five Thousand Dollars ($175,000) has been funded on April 27, 2005 (the “Initial Closing”), the principal amount of Three Hundred Thousand Dollars ($300,000) shall be funded on June 21, 2005, provided that the conditions in Section 7 hereof have been satisfied (the “Second Closing”), and the principal amount of $125,000 shall be funded on July 11, 2005, provided that the conditions set forth in Section 8 hereof have been satisfied (the “Third Closing”) (collectively, referred to as the “Closings” and individually referred to as the “Closing”). The Lender shall fund each Closing as soon as practicable, but shall be entitled to a five (5) business day grace period to process the funding at each Closing.

2.

Principal and Interest. For value received, the Company hereby promises to pay to the order of the Lender on, or before January 27, 2006 (the “Maturity Date”) in lawful money of the United States of America and in immediately available funds the principal sum of Six Hundred Thousand Dollars ($600,000) together with interest on the unpaid principal of this Note at the rate of twelve percent (12%) per year (computed on the basis of a 365-day year and the actual days elapsed) from the date of each Closing until paid.

3.

Scheduled Principal and Interest Payments of the Note. The Company shall make weekly scheduled payments (“Scheduled Payments”) as set forth on Schedule A. The first Scheduled Payment shall be due and payable on June 27, 2005, and each succeeding Scheduled Payment shall be due and payable on the first business day of each succeeding week thereafter for a total of fourteen (14) Scheduled Payments or until all amounts due hereunder have been paid, if sooner.

4.

Right of Prepayment. Notwithstanding the Scheduled Payments pursuant to Section 3, the Company at its option shall have the right to prepay, with three (3) business days advance written notice, a portion or all outstanding principal of the Note. The prepayment price shall be equal to the amount of principal prepaid, plus interest accrued on the outstanding principal prepaid. There shall be no prepayment fee or penalty.

5.

Fees. The Company shall pay the Lender (a) a commitment fee comprising of (i) ten percent (10%) of the gross proceeds of the first $350,000 funded under this Note, of which $17,500 has been paid out of the gross proceeds of the Initial Closing and $17,500 shall be paid out of the gross proceeds of the Second Closing, (ii) seven and one half percent (7.5%) of the gross proceeds of the remaining amounts to be funded under this Note which shall be paid pro rata out of the gross proceeds of the Second Closing and the Third Closing, and (iii) a warrant to purchase 1,000,000 shares of Common Stock (“Warrant Shares”) at an exercise price of $0.20 for a period of five (5) years; and (b) a fee of $15,000 as a structuring fee, of which $10,000 has been paid and $5,000 shall be paid directly from the gross proceeds of the Second Closing. The warrant shall be exercisable on a cash basis, except that if there is an event of default under the Transaction Documents, the Lender shall have the option to exercise the warrant on a cashless basis. The Company shall include the Warrant Shares on the Registration Statement. The Company shall also pay all amounts owed to Kirkpatrick & Lockhart Nicholson Graham, LLP directly out of the gross proceeds of the Second Closing.

6.

Conditions to the Lender’s Obligations to the Initial Closing. The obligation of the Lender hereunder to fund the Initial Closing is subject to the satisfaction, at or before the Initial Closing, of each of the following conditions, provided that these conditions are for the Lender’s sole benefit and may be waived by the Lender at any time in its sole discretion:

a.

The Company shall have executed the Transaction Documents, and delivered the same to the Lender.

b.

The Company shall have provided to the Lender a certificate of good standing from the Secretary of State of the Company’s State of incorporation.

2

c.

The Company shall have obtained the approval of its board of directors and a majority of its outstanding shares of capital stock (voting as separate classes, if required by applicable law) to approve and ratify this transaction.

d.

Matthew L. Schissler and Stephanie A. Schissler shall have delivered to the Escrow Agent the Pledged Shares as well as executed and medallion guaranteed stock powers as required pursuant to the Pledge Agreement.

7.

Conditions to the Lender’s Obligations to the Second Closing. The obligation of the Lender hereunder to fund the Second Closing is subject to the satisfaction, at or before the Second Closing, of each of the following conditions, provided that these conditions are for the Lender’s sole benefit and may be waived by the Lender at any time in its sole discretion:

a.

The Company shall have provided the Lender written notice that Company has received a written comment letter from the SEC in connection with the Registration Statement or that the Registration Statement has been declared effective without comment.

b.

One half of all amounts past due and currently due to Tedder, James, Worden & Associates, P.A. have been paid or held in escrow out of the gross proceeds of the Second Closing.

c.

No Events of Default shall have occurred under the Transaction Documents.

8.

Conditions to the Lender’s Obligations to fund the Third Closing. The obligation of the Lender hereunder to fund the Third Closing is subject to the satisfaction, at or before the Third Closing, of each of the following conditions, provided that these conditions are for the Lender’s sole benefit and may be waived by the Lender at any time in its sole discretion:

a.

All amounts past due and all amounts currently due to Tedder, James, Worden & Associates, P.A. have been satisfied or held in escrow out of the gross proceeds of the Third Closing.

b.

No event of default shall have occurred under the SEDA.

c.

No event of default shall have occurred under the Transaction Documents.

9.

Waiver and Consent. To the fullest extent permitted by law and except as otherwise provided herein, the Company waives demand, presentment, protest, notice of dishonor, suit against or joinder of any other person, and all other requirements necessary to charge or hold the Company liable with respect to this Note.

10.

Costs, Indemnities and Expenses. In the event of default as described herein, the Company agrees to pay all reasonable fees and costs incurred by the Lender in collecting or securing or attempting to collect or secure this Note, including reasonable attorneys’ fees and expenses, whether or not involving litigation, collecting upon any judgments and/or appellate or bankruptcy proceedings. The Company agrees to pay any documentary stamp taxes, intangible 

3

taxes or other taxes which may now or hereafter apply to this Note or any payment made in respect of this Note, and the Company agrees to indemnify and hold the Lender harmless from and against any liability, costs, attorneys’ fees, penalties, interest or expenses relating to any such taxes, as and when the same may be incurred.

11.

Secured Nature of the Note. This Note is secured by the Pledged Shares as defined in the Pledge Agreement.

12.

Event of Default. An “Event of Default” shall be deemed to have occurred upon the occurrence of any of the following, provided that the Company does not cure such Event of Default within ten (10) days of receipt of written notice of the Event of Default from the Lender: (i) failure by the Company to pay amounts due hereunder, including principal, interest, costs, indemnities, or expenses within five (5) calendar days of a Scheduled Payment due date or the Maturity Date; (ii) failure by the Company to satisfy any of its other obligations or requirements or comply with any of its other agreements under this Note; (iii) any proceedings under any bankruptcy laws of the United States of America or under any insolvency, not disclosed to the Lender, reorganization, receivership, readjustment of debt, dissolution, liquidation or any similar law or statute of any jurisdiction now or hereinafter in effect (whether in law or at equity) is filed by or against the Company or for all or any part of its property; or (iv) a breach by the Company of its obligations under the Pledge Agreement or any other related agreements hereunder between the Company and the Lender of even date herewith which is not cured by the Company by any applicable cure period therein. Upon an Event of Default (as defined above), the entire principal balance and accrued interest outstanding under this Note, and all other obligations of the Company under this Note, shall be immediately due and payable without any action on the part of the Lender, interest shall accrue on the unpaid principal balance at twenty four percent (24%) per year or the highest rate permitted by applicable law, if lower and the Lender shall be entitled to seek and institute any and all remedies available to it.

13.

Maximum Interest Rate. In no event shall any agreed to or actual interest charged, reserved or taken by the Lender as consideration for this Note exceed the limits imposed by New Jersey law. In the event that the interest provisions of this Note shall result at any time or for any reason in an effective rate of interest that exceeds the maximum interest rate permitted by applicable law, then without further agreement or notice the obligation to be fulfilled shall be automatically reduced to such limit and all sums received by the Lender in excess of those lawfully collectible as interest shall be applied against the principal of this Note immediately upon the Lender’s receipt thereof, with the same force and effect as though the Company had specifically designated such extra sums to be so applied to principal and the Lender had agreed to accept such extra payment(s) as a premium-free prepayment or prepayments.

14.

Issuance of Capital Stock. So long as any portion of this Note is outstanding, with the exception of Common Stock issued pursuant to the SEDA, the Company shall not, without the prior written consent of the Lender, (i) issue or sell shares of Common Stock or preferred stock (ii) issue any warrant, option, right, contract, call, or other security instrument granting the holder thereof, the right to acquire Common Stock (iii) enter into any security instrument granting the holder a security interest in any and all assets of the Company, or (iv) file any registration statement on Form S-8. 

4

15.

Cancellation of Note. Upon the repayment by the Company of all of its obligations hereunder to the Lender, including, without limitation, the principal amount of this Note, plus accrued but unpaid interest, the indebtedness evidenced hereby shall be deemed canceled and paid in full. Except as otherwise required by law or by the provisions of this Note, payments received by the Lender hereunder shall be applied first against expenses and indemnities, next against interest accrued on this Note, and next in reduction of the outstanding principal balance of this Note.

16.

Severability. If any provision of this Note is, for any reason, invalid or unenforceable, the remaining provisions of this Note will nevertheless be valid and enforceable and will remain in full force and effect. Any provision of this Note that is held invalid or unenforceable by a court of competent jurisdiction will be deemed modified to the extent necessary to make it valid and enforceable and as so modified will remain in full force and effect.

17.

Amendment and Waiver. This Note may be amended, or any provision of this Note may be waived, provided that any such amendment or waiver will be binding on a party hereto only if such amendment or waiver is set forth in a writing executed by the parties hereto. The waiver by any such party hereto of a breach of any provision of this Note shall not operate or be construed as a waiver of any other breach.

18.

Successors. Except as otherwise provided herein, this Note shall bind and inure to the benefit of and be enforceable by the parties hereto and their permitted successors and assigns.

19.

Assignment. This Note shall not be directly or indirectly assignable or delegable by the Company. The Lender may assign this Note as long as such assignment complies with the Securities Act of 1933, as amended.

20.

No Strict Construction. The language used in this Note will be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction will be applied against any party.

21.

Further Assurances. Each party hereto will execute all documents and take such other actions as the other party may reasonably request in order to consummate the transactions provided for herein and to accomplish the purposes of this Note.

22.

Notices, Consents, etc. Any notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one (1) trading day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be:

5

	If to Company:

	Cord Blood America, Inc. 

	 	9000 W. Sunset Boulevard, Suite 4000

	 	Los Angeles, CA 90069

	 	Attention: Matthew Schissler

	 	Telephone: (310) 432-4090

	 	Facsimile: (310) 432-4098

	 	 
	With a Copy to:

	Kirkpatrick & Lockhart Nicholson Graham, LLP

	 	201 South Biscayne Boulevard, Suite 2000

	 	Miami, Florida 33131

	 	Attention: Clayton E. Parker, Esquire

	 	Telephone: (305) 539-3306 

	 	Facsimile: (305) 358-7095 

	 	 
	If to the Lender:

	Cornell Capital Partners, LP

	 	101 Hudson Street, Suite 3700

	 	Jersey City, NJ 07302

	 	Attention: Mark A. Angelo

	 	Telephone: (201) 985-8300

	 	Facsimile: (201) 985-8744

or at such other address and/or facsimile number and/or to the attention of such other person as the recipient party has specified by written notice given to each other party three (3) trading days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile machine containing the time, date, recipient facsimile number and an image of the first page of such transmission or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

23.

Remedies, Other Obligations, Breaches and Injunctive Relief. The Lender’s remedies provided in this Note shall be cumulative and in addition to all other remedies available to the Lender under this Note, at law or in equity (including a decree of specific performance and/or other injunctive relief), no remedy of the Lender contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit the Lender’s right to pursue actual damages for any failure by the Company to comply with the terms of this Note. No remedy conferred under this Note upon the Lender is intended to be exclusive of any other remedy available to the Lender, pursuant to the terms of this Note or otherwise. No single or partial exercise by the Lender of any right, power or remedy hereunder shall preclude any other or further exercise thereof. The failure of the Lender to exercise any right or remedy under this Note or otherwise, or delay in exercising such right or remedy, shall not operate as a waiver thereof. Every right and remedy of the Lender under any document executed in connection with this transaction may be exercised from time to time and as often as may be deemed expedient by the Lender. The Company acknowledges that a breach by it of its 

6

obligations hereunder will cause irreparable harm to the Lender and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Lender shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, and specific performance without the necessity of showing economic loss and without any bond or other security being required.

24.

Governing Law; Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New Jersey, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New Jersey or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New Jersey. Each party hereby irrevocably submits to the exclusive jurisdiction of the Superior Court of the State of New Jersey sitting in Hudson County, New Jersey and the United States Federal District Court for the District of New Jersey sitting in Newark, New Jersey, for the adjudication of any dispute hereunder or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.

25.

No Inconsistent Agreements. None of the parties hereto will hereafter enter into any agreement, which is inconsistent with the rights granted to the parties in this Note.

26.

Third Parties. Nothing herein expressed or implied is intended or shall be construed to confer upon or give to any person or entity, other than the parties to this Note and their respective permitted successor and assigns, any rights or remedies under or by reason of this Note.

27.

Waiver of Jury Trial. AS A MATERIAL INDUCEMENT FOR THE LENDER TO LOAN TO THE COMPANY THE MONIES HEREUNDER, THE COMPANY HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING RELATED IN ANY WAY TO THIS AGREEMENT AND/OR ANY AND ALL OF THE OTHER DOCUMENTS ASSOCIATED WITH THIS TRANSACTION.

28.

Entire Agreement. This Note (including any recitals hereto) set forth the entire understanding of the parties with respect to the subject matter hereof, and shall not be modified or affected by any offer, proposal, statement or representation, oral or written, made by or for any party in connection with the negotiation of the terms hereof, and may be modified only by instruments signed by all of the parties hereto.

[REMAINDER OF PAGE INTENTIONALY LEFT BLANK]

7

IN WITNESS WHEREOF, this Promissory Note is executed by the undersigned as of the date hereof.

	 	CORNELL CAPITAL PARTNERS, LP

	 	 
	 	By: Yorkville Advisors, LLC

	 	Its: General Partner

	 	 
	 	By: ______________________________

	 	Name:

Mark Angelo

	 	Its:

Portfolio Manager

	 	 
	 	 
	 	CORD BLOOD AMERICA, INC.

	 	 
	 	By: _____________________________

	 	Name:

 Matthew Schissler

	 	Title:

 Chairman and Chief Executive Officer

8

	SCHEDULE A

	PAYMENT SCHEDULE

	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	Scheduled Payment Due Date

	Payment Amount

	 	 	 	 	 	 
	June 27, 2005

	25,000.00

	 	 	 	 	 	 
	July 4, 2005

	25,000.00

	 	 	 	 	 	 
	July 11, 2005

	25,000.00

	 	 	 	 	 	 
	July 18, 2005

	50,000.00

	 	 	 	 	 	 
	July 25, 2005

	50,000.00

	 	 	 	 	 	 
	August 1, 2005

	50,000.00

	 	 	 	 	 	 
	August 8, 2005

	50,000.00

	 	 	 	 	 	 
	August 15, 2005

	50,000.00

	 	 	 	 	 	 
	August 22, 2005

	50,000.00

	 	 	 	 	 	 
	August 29, 2005

	50,000.00

	 	 	 	 	 	 
	September 5, 2005

	50,000.00

	 	 	 	 	 	 
	September 12, 2005

	50,000.00

	 	 	 	 	 	 
	September 19, 2005

	50,000.00

	 	 	 	 	 	 
	September 26, 2005

	82,452.05

	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]